Cumberland Pharmaceuticals (CPIX) EBT Margin (2016 - 2025)
Historic EBT Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 23.44%.
- Cumberland Pharmaceuticals' EBT Margin fell 66500.0% to 23.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.18%, marking a year-over-year increase of 211400.0%. This contributed to the annual value of 17.08% for FY2024, which is 11900.0% down from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported EBT Margin of 23.44% as of Q3 2025, which was down 66500.0% from 6.73% recorded in Q2 2025.
- Cumberland Pharmaceuticals' EBT Margin's 5-year high stood at 10.7% during Q1 2025, with a 5-year trough of 67.11% in Q4 2023.
- In the last 5 years, Cumberland Pharmaceuticals' EBT Margin had a median value of 12.49% in 2022 and averaged 14.69%.
- In the last 5 years, Cumberland Pharmaceuticals' EBT Margin plummeted by -406800bps in 2023 and then surged by 483400bps in 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' EBT Margin (Quarter) stood at 52.59% in 2021, then skyrocketed by 50bps to 26.43% in 2022, then plummeted by -154bps to 67.11% in 2023, then soared by 72bps to 18.77% in 2024, then dropped by -25bps to 23.44% in 2025.
- Its EBT Margin was 23.44% in Q3 2025, compared to 6.73% in Q2 2025 and 10.7% in Q1 2025.